课题基金 / 基金详情

Innate Immune Defect and Neutrophilic Inflammation in Cystic Fibrosis

Innate Immune Defect and Neutrophilic Inflammation in Cystic Fibrosis
囊性纤维化中的先天免疫缺陷和中性粒细胞炎症
批准号:
10672206
负责人:
GUOSHUN WANG
金额:
$36.84万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-01 至 2024-07-31
关键词:
Abnormal NeutrophilAddressAffectAgonistApoptosisArachidonic AcidsAttentionBacteriaBacterial InfectionsBlocking AntibodiesBone Marrow TransplantationCategoriesCell DeathCellsCessation of lifeCharacteristicsChemicalsChemotactic FactorsChloride ChannelsChronicChronic DiseaseClinicalComplement ActivationComplicationCyclic AMPCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDNA Sequence AlterationDataDefectDevelopmentDiseaseEpithelial CellsEpitheliumFDA approvedGenesGenetic DiseasesHumanImmuneInfiltrationInflammationInflammatoryInflammatory ResponseInhalationInterleukin-8Intravenous infusion proceduresIrrigationKnock-outKnockout MiceKnowledgeKnowledge acquisitionLabelLeukotriene B4LinkLiquid ChromatographyLiquid substanceLive BirthLungMacrophageMarrowMicrobeModificationMolecularMorbidity - disease rateMutationMyelogenousNecrosisOrganOutcomes ResearchOxidantsPathogenesisPathologicPathologyPathway interactionsPatientsPhagocytesPharmaceutical PreparationsPharmacologic SubstancePlayProductionPseudomonas aeruginosaPulmonary ChallengePulmonary Cystic FibrosisPulmonary InflammationPulmonary PathologyRegulator GenesResearchRoleSourceStructureSystemTestingTimeTissuesTracerUnited StatesWild Type MouseZymosanairway obstructionantagonistautosomebeta-Glucanscell typechemokinecystic fibrosis airway epitheliacystic fibrosis mousecystic fibrosis patientscytokineeffective interventioneffective therapyextracellularformyl peptidegene therapyinsightloss of functionmonocytemortalityneutrophilnew therapeutic targetnovelrational designreceptorrecruittandem mass spectrometrytherapeutically effective

项目摘要

项目成果

GUOSHUN WANG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT Cystic fibrosis (CF) is one of the most common and deadly genetic disorders, affecting ~1/3,000 live births in the United States. The responsible genetic mutations are linked to the gene that encodes CF Transmembrane-conductance Regulator (CFTR), a cAMP-activated chloride channel. Although this disease affects almost all organs and systems, its lung complications claim the most morbidity and mortality. The prominent lung pathology is marked by chronic bacterial infection, persistent neutrophilic inflammation, and purulent small airway obstruction, of which persistent lung inflammation is responsible for lung structure damage and function loss. Even though the CF molecular defect was discovered three decades ago, the link between the CFTR chloride channel defect and the destructive lung inflammation has not been defined. Such a knowledge gap impedes any informed development of effective therapies for CF. The current proposal is to address this outstanding problem in the field. Our overarching hypothesis is that CFTR loss-of-function in marrow-derived innate immune cells compromises their ability to molecularly modify and functionally deactivate inflammatory agonists, leading to excessive stimulation and neutrophilic inflammation in CF lungs. To test this hypothesis, we propose three specific aims: Aim 1: Determine that lineage-specific CFTR loss-of-function in neutrophils and monocytes/macrophages leads to persistent neutrophilic inflammation in the lung differentially; Aim 2: Determine that CF lung neutrophilic inflammation is due to neutrophil excessive recruitment, reduced apoptosis, and/or inefficient efferocytosis; Aim 3: Define that CF neutrophils and macrophages are compromised in chemical modification and functional deactivation of neutrophil chemotactic factors. Completion of this research will provide novel insights into CF lung disease pathogenesis. The new knowledge obtained will guide the rational design of interventions for effective treatment of this devastating disease.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3389/fimmu.2023.1242381
发表时间: 2023
期刊: FRONTIERS IN IMMUNOLOGY
影响因子: 7.3
作者: [Wellems, Dianne, Hu, Yawen, Jennings, Scott, Wang, Guoshun]
通讯作者: Wang, Guoshun
DOI: 10.1038/s42003-022-04101-5
发表时间: 2022-10-26
期刊: Communications biology
影响因子: 5.9
作者: []
通讯作者:
DOI: 10.3390/cells12121555
发表时间: 2023-06-06
期刊: CELLS
影响因子: 6
作者: [Wang, Guoshun]
通讯作者: Wang, Guoshun
Innate Immune Defect and Neutrophilic Inflammation in Cystic Fibrosis
  • 批准号:
    10470027
  • 项目类别:
  • 资助金额:
    $36.84万
  • 财政年份:
    2020
  • 负责人:
    GUOSHUN WANG
  • 依托单位:
Innate Immune Defect and Neutrophilic Inflammation in Cystic Fibrosis
  • 批准号:
    10247817
  • 项目类别:
  • 资助金额:
    $37.15万
  • 财政年份:
    2020
  • 负责人:
    GUOSHUN WANG
  • 依托单位:
Alcohol, GILZ and LPS Sepsis
  • 批准号:
    9315672
  • 项目类别:
  • 资助金额:
    $17.34万
  • 财政年份:
    2016
  • 负责人:
    GUOSHUN WANG
  • 依托单位:
Systematic Responses of GILZ Regulatory Network to Alcohol
  • 批准号:
    8582740
  • 项目类别:
  • 资助金额:
    $17.1万
  • 财政年份:
    2013
  • 负责人:
    GUOSHUN WANG
  • 依托单位:
海外基金